• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice.

作者信息

Moshfeghi Darius M, Berrocal Audina M

出版信息

Ophthalmology. 2011 Jul;118(7):1227-8. doi: 10.1016/j.ophtha.2011.04.028.

DOI:10.1016/j.ophtha.2011.04.028
PMID:21724044
Abstract
摘要

相似文献

1
Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice.贝伐单抗时代的早产儿视网膜病变：将BEAT-ROP研究结果纳入临床实践
Ophthalmology. 2011 Jul;118(7):1227-8. doi: 10.1016/j.ophtha.2011.04.028.
2
Bevacizumab for ROP.贝伐单抗用于治疗早产儿视网膜病变。
Ophthalmology. 2012 Feb;119(2):431-2; author reply 432. doi: 10.1016/j.ophtha.2011.11.021.
3
Bevacizumab for retinopathy of prematurity.贝伐单抗用于治疗早产儿视网膜病变。
Ophthalmology. 2012 May;119(5):1091-2; author reply 1092-2.e1. doi: 10.1016/j.ophtha.2012.01.056.
4
Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.玻璃体内及前房内注射贝伐单抗治疗早产儿视网膜病变的新生血管并发症。
Acta Ophthalmol. 2008 Sep;86(6):698-700. doi: 10.1111/j.1600-0420.2007.01106.x.
5
Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.玻璃体内注射贝伐单抗治疗3期及以上早产儿视网膜病变的疗效
Ir Med J. 2011 Jul-Aug;104(7):197.
6
Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan.贝伐单抗治疗早产儿视网膜病变的效果和并发症：台湾多中心研究。
Ophthalmology. 2011 Jan;118(1):176-83. doi: 10.1016/j.ophtha.2010.04.018. Epub 2010 Jul 29.
7
Bevacizumab for retinopathy of prematurity.贝伐单抗用于早产儿视网膜病变
N Engl J Med. 2011 Feb 17;364(7):677-8. doi: 10.1056/NEJMe1100248.
8
Management of retinopathy of prematurity.早产儿视网膜病变的管理。
Arch Dis Child Fetal Neonatal Ed. 2013 Sep;98(5):F454-6. doi: 10.1136/archdischild-2013-303933. Epub 2013 Jun 27.
9
Current and future trends in treatment of severe retinopathy of prematurity.当前和未来治疗严重早产儿视网膜病变的趋势。
Clin Perinatol. 2013 Jun;40(2):297-310. doi: 10.1016/j.clp.2013.02.005.
10
Incidence and result of treatment-demanding retinopathy of prematurity using revised U.S. screening guidelines.采用修订后的美国筛查指南评估治疗性早产儿视网膜病变的发生率和结果。
Am J Perinatol. 2012 Nov;29(10):827-31. doi: 10.1055/s-0032-1321495. Epub 2012 Jul 6.

引用本文的文献

1
OCT macular changes in type 1 ROP following Ranibizumab injections.雷珠单抗注射后1型视网膜病变的黄斑光学相干断层扫描变化
Int J Retina Vitreous. 2025 Apr 17;11(1):47. doi: 10.1186/s40942-025-00664-7.
2
Retinopathy of Prematurity and MicroRNAs.早产儿视网膜病变与微小RNA
Biomedicines. 2025 Feb 7;13(2):400. doi: 10.3390/biomedicines13020400.
3
Retinopathy of prematurity: from oxygen management to molecular manipulation.早产儿视网膜病变：从氧疗管理到分子调控
Mol Cell Pediatr. 2023 Sep 15;10(1):12. doi: 10.1186/s40348-023-00163-5.
4
Outcomes of near confluent laser versus combined less dense laser and bevacizumab treatment of prethreshold ROP Type 1 Zone 2: a randomized controlled trial.阈值前 1 型 ROP 区 2 中近融合激光与联合低密度激光和贝伐单抗治疗的结局：一项随机对照试验。
BMC Ophthalmol. 2022 Nov 28;22(1):454. doi: 10.1186/s12886-022-02689-0.
5
Retinopathy of prematurity: a review of epidemiology and current treatment strategies.早产儿视网膜病变：流行病学及当前治疗策略综述
Clin Exp Pediatr. 2022 Mar;65(3):115-126. doi: 10.3345/cep.2021.00773. Epub 2021 Oct 12.
6
The treatment and risk factors of retinopathy of prematurity in neonatal intensive care units.新生儿重症监护病房中早产儿视网膜病变的治疗及危险因素
BMC Ophthalmol. 2018 Nov 20;18(1):301. doi: 10.1186/s12886-018-0973-1.
7
Functional and Structural Outcomes of Temporal Zone II-Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab in Retinopathy of Prematurity.颞侧II区保留型激光光凝联合玻璃体内注射贝伐单抗治疗早产儿视网膜病变的功能和结构预后
J Ophthalmol. 2018 Sep 27;2018:2376240. doi: 10.1155/2018/2376240. eCollection 2018.
8
Ocular Adverse Effects of Intravitreal Bevacizumab Are Potentiated by Intermittent Hypoxia in a Rat Model of Oxygen-Induced Retinopathy.在氧诱导视网膜病变大鼠模型中，间歇性缺氧会增强玻璃体内注射贝伐单抗的眼部不良反应。
J Ophthalmol. 2017;2017:4353129. doi: 10.1155/2017/4353129. Epub 2017 Jul 9.
9
Recurrence of Retinopathy of Prematurity in Zone II Stage 3+ after Ranibizumab Treatment: A Retrospective Study.雷珠单抗治疗后Ⅱ区3+期早产儿视网膜病变的复发：一项回顾性研究
J Ophthalmol. 2017;2017:5078565. doi: 10.1155/2017/5078565. Epub 2017 Apr 9.
10
Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy.眼部使用酮咯酸与全身使用枸橼酸咖啡因对大鼠氧诱导性视网膜病变的药理协同作用
Pediatr Res. 2016 Oct;80(4):554-65. doi: 10.1038/pr.2016.105. Epub 2016 May 16.